<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Suggested empiric intravenous antibiotic regimens for treatment of bacterial tracheitis in children</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Suggested empiric intravenous antibiotic regimens for treatment of bacterial tracheitis in children</h1>
<div class="graphic"><div class="figure"><div class="ttl">Suggested empiric intravenous antibiotic regimens for treatment of bacterial tracheitis in children</div><div class="cntnt"><table cellspacing="0"><colgroup span="2" width="50%"></colgroup> <tbody> <tr> <td class="subtitle1" colspan="2">Antimicrobial regimens</td> </tr> <tr> <td class="subtitle2">Our preferred regimen</td> <td class="subtitle2">Alternative options</td> </tr> <tr class="divider_bottom"> <td> <ul> <li>Vancomycin 15 mg/kg per <strong>dose</strong> every 6 to 8 hours (maximum daily dose: 4 g)*<sup>¶</sup> </li> <li><strong>Plus</strong> <strong>1</strong> of the following: <ul> <li>Ceftriaxone 50 mg/kg per <strong>dose</strong> every 12 to 24 hours (maximum daily dose: 2 g), <strong>or</strong> </li> <li>Cefotaxime (if available) 150 to 200 mg/kg per <strong>day</strong> in 4 divided doses (maximum dose 2 g)<sup>¶</sup>, <strong>or</strong> </li> <li>Ampicillin-sulbactam 150 to 200 mg/kg (of ampicillin component) per <strong>day</strong> in 4 divided doses (maximum daily dose: 8 g)<sup>¶</sup> </li> </ul> </li> </ul> </td> <td> <ul> <li>Linezolid can be substituted for vancomycin<br/> Linezolid dosing:<sup>Δ</sup> <ul class="decimal_heading"> <li>&lt;12 years: 10 mg/kg per <strong>dose</strong> every 8 hours (maximum dose 600 mg) </li> <li>≥12 years: 600 mg per <strong>dose</strong> every 12 hours </li> </ul> </li> <li>Monotherapy with ceftaroline is a reasonable alternative to combination therapy<br/> Ceftaroline dosing:<sup>Δ</sup> <ul class="decimal_heading"> <li>15 mg/kg per <strong>dose</strong> every 8 hours (maximum dose 600 mg)<sup>¶</sup> </li> </ul> </li> <li>Clindamycin can be substituted for vancomycin for nonsevere/non-life-threating infections in settings where the prevalence of clindamycin resistance among <em>Staphylococcus aureus</em> isolates is low<sup>◊</sup><br/> Clindamycin dosing: <ul class="decimal_heading"> <li>40 mg/kg per <strong>day</strong> in 3 divided doses (maximum daily dose: 2.7 g) </li> </ul> </li> </ul> </td> </tr> <tr class="divider_bottom"> <td colspan="2"><strong>For patients with potential severe hypersensitivity to beta-lactam antibiotics (eg, penicillin, cephalosporin):</strong> <ul class="decimal_heading"> <li>Levofloxacin or ciprofloxacin can be substituted for the cephalosporin/ampicillin-sulbactam component of the regimen<br/> Levofloxacin dosing: <ul class="decimal_heading"> <li>6 months to 5 years: 10 mg/kg per <strong>dose</strong> every 12 hours (maximum daily dose: 500 mg)<sup>¶</sup> </li> <li>≥5 years: 10 mg/kg per <strong>dose</strong> once daily (maximum daily dose: 500 mg)<sup>Δ</sup> </li> </ul> Ciprofloxacin dosing: <ul class="decimal_heading"> <li>20 to 30 mg/kg per <strong>day</strong> in 2 divided doses (maximum daily dose: 800 mg)<sup>¶</sup> </li> </ul> </li> </ul> </td> </tr> <tr> <td colspan="2"><strong>For patients with nonanaphylactic hypersensitivity to penicillin and cephalosporin:</strong> <ul class="decimal_heading"> <li>Aztreonam or meropenem can be substituted for the cephalosporin/ampicillin-sulbactam component of the regimen<br/> Aztreonam dosing: <ul class="decimal_heading"> <li>90 to 120 mg/kg per <strong>day</strong> in 3 to 4 divided doses (maximum daily dose: 8 g)<sup>¶</sup> </li> </ul> Meropenem dosing: <ul class="decimal_heading"> <li>20 mg/kg per <strong>dose</strong> every 8 hours (maximum daily dose 6 g)<sup>¶</sup> </li> </ul> </li> </ul> </td> </tr> </tbody></table></div><div class="graphic_lgnd">This table summarizes our recommendations for <em>empiric </em>antibiotic therapy for children with bacterial tracheitis. Final therapy decisions should be based upon results of cultures and susceptibility testing. Consultation with an expert in infectious diseases may be warranted for guidance regarding choice and duration of antimicrobial therapy.</div><div class="graphic_footnotes">* For life-threatening infections, vancomycin should given every 6 hours. Trough levels of 15 to 20 mcg/mL are suggested for severe infections. For further details, refer to separate UpToDate content on treatment of <em>S. aureus</em> infections in children.<br/>¶ Dose adjustment is necessary for patients with renal impairment. Refer to drug information topics for details.<br/>Δ Experience with these agents in children is limited. Consultation with an infectious diseases specialist is suggested.<br/><font class="lozenge">◊</font> Information regarding local susceptibility patterns can be obtained from local public health officials or hospital laboratories. The threshold prevalence of clindamycin-resistant <em>S. aureus</em> for choosing vancomycin varies from center to center, usually ranging from 10 to 25%, in an effort to balance the benefit of definitive therapy for the patient with the risk of increasing vancomycin resistance in the community. For further details, refer to separate UpToDate content on treatment of <em>S. aureus</em> infections in children.</div><div class="graphic_reference">References:

	<ol>
<li>American Academy of Pediatrics. Staphylococcus aureus. In: Red Book: 2018 Report of the Committee on Infectious Diseases, 31<sup>st</sup> ed, Kimberlin DW, Brady MT, Jackson MA, Long SS (Eds), American Academy of Pediatrics, Itasca, IL 2018. p.733.</li>
<li>American Academy of Pediatrics. Tables of antibacterial drug dosages. In: Red Book: 2018 Report of the Committee on Infectious Diseases, 31<sup>st</sup> ed, Kimberlin DW, Brady MT, Jackson MA, Long SS (Eds), American Academy of Pediatrics, Itasca, IL 2018. p.914.</li>
</ol></div><div id="graphicVersion">Graphic 58913 Version 5.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
